Abiopharma

SUNSTONE HOTEL INVESTORS, INC. (SHO) Reports the reporting period Financial Results SUNSTONE HOTEL INVESTORS, INC. (SHO) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 241005
• Net Income: 18557
• EPS: Not disclosed
• Cash and equivalents: 91134
  • 4 million, before expenses, of its common and preferred stock. From the start of this year through May 1, 2026, the Company has allocated a total of $
  • 2 million, before expenses, into repurchases of its common and preferred stock. The Company believes this repurchase activity has been completed at a discount and generated significant value for its stockholders. As of May 1, 2026, the Company has $
  • 3 million remaining under its existing stock repurchase program authorization. ​●Common stock: During the first quarter of 2026, the Company repurchased 3,184,768 shares at an average purchase price per share of $